Table 2

Comparison of total and sex-specific rates (expressed as numbers of patients per 10‚ÄČ000 patient years at risk) from the GPRD and MSGP4 for tuberculosis (TB), cystic fibrosis, sarcoidosis, fibrosing aleveolitis and pneumothorax. All GPRD rates are a weighted average of 1991 and 1992 figures